查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594416

發作性睡病治療市場：按藥物類別、發作性睡病類型、分銷管道分類 - 全球預測 2025-2030

Narcolepsy Treatment Market by Drug Class (CNS Stimulants, Decongestants, Serotonin Reuptake Inhibitors), Narcolepsy Type (Narcolepsy Type 1, Narcolepsy Type 2), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年發作性睡病治療市值為38.6億美元，預計到2024年將達到43.8億美元，複合年成長率為13.45%，到2030年將達到93.6億美元。

發作性睡病的治療包括多種治療性介入，旨在控制這種慢性神經系統疾病的症狀，其特徵是白天過度嗜睡和突然的肌肉無力（猝倒）。有效的發作性睡病治療的需要會影響患者的生活品質和生產力，需要改善睡眠調節和白天的警覺性。治療主要集中於藥物解決方案，如興奮劑、抗憂鬱症和羥丁酸鈉，以及行為療法和生活方式改變。發作性睡病治療的最終用途範圍涵蓋醫院、專科診所和居家照護等醫療機構，並且擴大透過遠端醫療服務獲得。

主要市場統計
基準年[2023] 38.6億美元
預測年份 [2024] 43.8億美元
預測年份 [2030] 93.6億美元
複合年成長率（%） 13.45%

影響市場的主要成長要素包括對發作性睡病的認知提高、診斷能力提高以及藥物治療的進步。睡眠障礙的日益普及以及全球對心理健康的日益關注正在擴大市場潛力。近年來，新型藥物傳輸系統和個人化醫療方法出現了巨大的商機，特別是那些針對Orexin胜肽的藥物，它們對於調節覺醒非常重要。公司可以透過投資研發、促進與學術機構的合作以及利用人工智慧進行藥物發現來抓住這些機會。

然而，市場成長受到多種挑戰的限制，包括高昂的治療成本、對發作性睡病發病機制的了解不足以及藥物核准的高監管障礙。此外，與目前藥物相關的副作用可能會抑制患者的依從性和接受度。設計永續且具成本效益的治療方法，尤其是副作用較少的治療方法，可以緩解這些限制。擴大對遺傳和分子因素的研究也可能導致新治療標靶的發現。

總體而言，市場動態在獨特的挑戰中帶來了動態的機會。透過專注於創新藥物治療、探索發作性睡病的神經生理學基礎以及改善醫療保健的可及性，公司可以在這個不斷發展的領域中佔據有利地位。這項策略重點將促進更全面、更有效的治療方法的發展。

市場動態：快速發展的發作性睡病治療市場的關鍵市場洞察

供給和需求的動態交互作用正在改變發作性睡病治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 睡眠障礙發作性睡病患者增加
    • 提高消費者對發作性睡病治療的認知
    • 政府增加發作性睡病治療的核准
  • 市場限制因素
    • 發作性睡病治療的副作用
  • 市場機會
    • 關於發作性睡病治療的研究活動增加
    • 優惠報銷政策的出現
  • 市場挑戰
    • 醫護人員短缺

波特的五力：駕馭發作性睡病治療市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解發作性睡病治療市場的外部影響

外部宏觀環境因素在塑造發作性睡病治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解發作性睡病治療市場的競爭格局

對發作性睡病治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣發作性睡病治療市場供應商的績效評估

FPNV定位矩陣是評估發作性睡病治療市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製發作性睡病治療市場的成功之路

發作性睡病治療市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 睡眠障礙發作性睡病增加
      • 提高消費者對發作性睡病治療的認知
      • 政府對嗜睡症藥物的核准增加
    • 抑制因素
      • 發作性睡病治療的副作用
    • 機會
      • 與發作性睡病治療相關的研究活動增加
      • 優惠報銷政策的出現
    • 任務
      • 醫護人員短缺
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章發作性睡病治療市場（依藥物類別）

  • 中樞神經系統興奮劑
  • 減充血劑
  • 血清素再回收抑制劑
  • 血管收縮劑

第7章發作性睡病治療市場（依發作性睡病類型）

  • 發作性睡病 1 型
  • 發作性睡病2型

第8章發作性睡病治療市場：按分銷管道

  • 藥局
  • 電子商務
  • 零售藥房

第9章美洲發作性睡病治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區發作性睡病治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的發作性睡病治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Addrenex Pharmaceuticals, Inc.
  • Arena Pharmaceuticals, Inc.
  • Avadel Pharmaceuticals plc
  • Axsome Therapeutics, Inc.
  • GlaxoSmithKline PLC
  • Graymark Healthcare Inc.
  • Harmony Biosciences LLC
  • Jazz Pharmaceuticals plc
  • Johnson & Johnson Services Inc.
  • Ligand Pharmaceuticals
  • Midas Pharma GmbH
  • Novartis AG
  • Pfizer Inc.
  • Shire Plc
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-036C5CF3B447

The Narcolepsy Treatment Market was valued at USD 3.86 billion in 2023, expected to reach USD 4.38 billion in 2024, and is projected to grow at a CAGR of 13.45%, to USD 9.36 billion by 2030.

Narcolepsy treatment encompasses a range of therapeutic interventions aimed at managing symptoms of this chronic neurological disorder, characterized by excessive daytime sleepiness and sudden muscle weakness (cataplexy). The necessity for effective narcolepsy treatment is driven by its impact on patient quality of life and productivity, necessitating improved sleep regulation and daytime alertness. Treatment applications primarily focus on pharmacological solutions, including stimulants, antidepressants, and sodium oxybate, as well as behavioral therapies and lifestyle modifications. The end-use scope for narcolepsy treatments spans healthcare settings such as hospitals, specialty clinics, and home care, with increasing accessibility through telehealth services.

KEY MARKET STATISTICS
Base Year [2023] USD 3.86 billion
Estimated Year [2024] USD 4.38 billion
Forecast Year [2030] USD 9.36 billion
CAGR (%) 13.45%

Key growth factors influencing the market include rising awareness about narcolepsy, improved diagnostic capabilities, and ongoing advancements in pharmacotherapy. The increasing prevalence of sleep disorders and a broader, global focus on mental health are expanding market potential. In recent years, significant opportunities have emerged with novel drug delivery systems and personalized medicine approaches, particularly in targeting orexin neuropeptides, which are crucial in regulating wakefulness. Companies could seize these opportunities by investing in R&D, fostering collaborations with academic institutions, and leveraging artificial intelligence for drug discovery.

However, market growth is constrained by several challenges, including the high cost of treatment, limited understanding of narcolepsy's etiology, and stringent regulatory hurdles for drug approval. Furthermore, side effects associated with current medications can impede patient adherence and acceptance. Innovating sustainable, cost-effective treatment options, particularly those with fewer side effects, can mitigate these limitations. Extending research into genetic or molecular factors may also unlock new therapeutic targets.

Overall, the market for narcolepsy treatment presents dynamic opportunities amid its inherent challenges. By focusing on innovation in drug therapies, exploring the neurophysiological underpinnings of narcolepsy, and enhancing healthcare accessibility, companies can position themselves advantageously in this evolving landscape. This strategic focus can facilitate the development of more comprehensive and effective treatment modalities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Narcolepsy Treatment Market

The Narcolepsy Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing cases of sleep disorder narcolepsy
    • Growing consumer awareness regarding narcolepsy treatment
    • Rising government approvals for narcolepsy therapeutics
  • Market Restraints
    • Adverse effects of the narcolepsy treatment
  • Market Opportunities
    • Rise in the research activities related to the narcolepsy treatment
    • Emergence of favorable reimbursement policies
  • Market Challenges
    • Shortage of medical professionals

Porter's Five Forces: A Strategic Tool for Navigating the Narcolepsy Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Narcolepsy Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Narcolepsy Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Narcolepsy Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Narcolepsy Treatment Market

A detailed market share analysis in the Narcolepsy Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Narcolepsy Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Narcolepsy Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Narcolepsy Treatment Market

A strategic analysis of the Narcolepsy Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Narcolepsy Treatment Market, highlighting leading vendors and their innovative profiles. These include Addrenex Pharmaceuticals, Inc., Arena Pharmaceuticals, Inc., Avadel Pharmaceuticals plc, Axsome Therapeutics, Inc., GlaxoSmithKline PLC, Graymark Healthcare Inc., Harmony Biosciences LLC, Jazz Pharmaceuticals plc, Johnson & Johnson Services Inc., Ligand Pharmaceuticals, Midas Pharma GmbH, Novartis AG, Pfizer Inc., Shire Plc, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Narcolepsy Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Class, market is studied across CNS Stimulants, Decongestants, Serotonin Reuptake Inhibitors, and Vasopressors.
  • Based on Narcolepsy Type, market is studied across Narcolepsy Type 1 and Narcolepsy Type 2.
  • Based on Distribution Channel, market is studied across Drug Stores, E-commerce, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of sleep disorder narcolepsy
      • 5.1.1.2. Growing consumer awareness regarding narcolepsy treatment
      • 5.1.1.3. Rising government approvals for narcolepsy therapeutics
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse effects of the narcolepsy treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in the research activities related to the narcolepsy treatment
      • 5.1.3.2. Emergence of favorable reimbursement policies
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of medical professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Narcolepsy Treatment Market, by Drug Class

  • 6.1. Introduction
  • 6.2. CNS Stimulants
  • 6.3. Decongestants
  • 6.4. Serotonin Reuptake Inhibitors
  • 6.5. Vasopressors

7. Narcolepsy Treatment Market, by Narcolepsy Type

  • 7.1. Introduction
  • 7.2. Narcolepsy Type 1
  • 7.3. Narcolepsy Type 2

8. Narcolepsy Treatment Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Drug Stores
  • 8.3. E-commerce
  • 8.4. Retail Pharmacies

9. Americas Narcolepsy Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Narcolepsy Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Narcolepsy Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Addrenex Pharmaceuticals, Inc.
  • 2. Arena Pharmaceuticals, Inc.
  • 3. Avadel Pharmaceuticals plc
  • 4. Axsome Therapeutics, Inc.
  • 5. GlaxoSmithKline PLC
  • 6. Graymark Healthcare Inc.
  • 7. Harmony Biosciences LLC
  • 8. Jazz Pharmaceuticals plc
  • 9. Johnson & Johnson Services Inc.
  • 10. Ligand Pharmaceuticals
  • 11. Midas Pharma GmbH
  • 12. Novartis AG
  • 13. Pfizer Inc.
  • 14. Shire Plc
  • 15. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. NARCOLEPSY TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. NARCOLEPSY TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. NARCOLEPSY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. NARCOLEPSY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NARCOLEPSY TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NARCOLEPSY TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY CNS STIMULANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DECONGESTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY SEROTONIN REUPTAKE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY VASOPRESSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 1, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 2, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. NARCOLEPSY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. NARCOLEPSY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023